Mereo BioPharma (MREO) Tax Rate (2023 - 2025)
Mereo BioPharma (MREO) posted quarterly Tax Rate of 141.67% for Q4 2025, up 1250.0% year-on-year from 10.49% in Q4 2024, and up 8.11% on a QoQ basis from 154.17% in Q4 2024.
Mereo BioPharma (MREO) Tax Rate (2023 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has reported Tax Rate for 3 consecutive years, with 141.67% the latest figure, recorded in Q4 2025.
- Quarterly Tax Rate rose 1250.0% year-over-year to 141.67% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 29.16% (down 614.0% YoY) and the FY2025 annual result came in at 24.87%, up 25.0% from the prior year.
- Tax Rate rose to 141.67% in Q4 2025 per MREO's latest filing, from 154.17% in the prior quarter.
- Over the last five years, Tax Rate for MREO reached as high as 5.52% in Q4 2023 and fell as low as 154.17% in Q4 2024.
- A 3-year average of 96.77% and a median of 141.67% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate slumped 15969 bps — and 2025, when it surged 1250 bps.
- Year by year, Tax Rate stood at 5.52% in 2023, then plunged by 2894 bps to 154.17% in 2024, then increased by 8 bps to 141.67% in 2025.
- According to Business Quant data, Tax Rate over the past three periods registered 141.67%, 154.17%, and 5.52% for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.67% |
| Dec 31, 2025 | -141.67% |
| Dec 31, 2025 | -141.67% |
| Dec 31, 2024 | -154.17% |
| Dec 31, 2024 | -154.17% |
| Dec 31, 2024 | -154.17% |
| Dec 31, 2023 | 5.52% |
| Dec 31, 2023 | 5.52% |
| Dec 31, 2023 | 5.52% |